EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Use of Hepatitis C Viremic Donors to Expand the Pediatric Donor Pool

Natasha Dilwali, Christopher Hartley iD, Paul K Sue iD, Wikrom Karnsakul iD

Pathogens · 2024

DOI: 10.3390/pathogens13110947 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Natasha Dilwali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Johns Hopkins University of Medicine, Baltimore, MD 21287…. Hauptthemen laut MEDLINE: Hepatitis C, Tissue Donors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of hepatitis C virus (HCV)-positive donors in organ transplantation has become increasingly viable due to advancements in direct-acting antiviral (DAA) therapies, which offer high cure rates. This review aims to evaluate the current practices, benefits, and challenges of utilizing HCV-positive donors for organ transplantation. The recent data show that transplant centers are progressively accepting HCV-positive donors for various organs, including kidneys, livers, and hearts, given the efficacy of post-transplant antiviral treatment. Using these donors has helped mitigate the organ shortage crisis, increasing the donor pool and reducing waitlist times. Despite these advantages, the approach raises concerns about viral transmission, long-term outcomes, and the cost-effectiveness of post-transplant DAA therapy. Furthermore, this review highlights the ethical implications of informed consent and the monitoring of HCV-negative recipients following transplantation. The outcomes from recent studies suggest that with proper management, transplantations from HCV-positive donors to HCV-negative recipients can be safe and effective, leading to excellent graft function and patient survival. This review synthesizes existing research and offers insights into optimizing protocols for future transplants involving HCV-positive donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CTissue DonorsChildHumansAntiviral AgentsDonor SelectionHepacivirusOrgan TransplantationTissue and Organ ProcurementViremia

Stichwörter der Autor:innen

HCV-positive donorsdirect-acting antiviral (DAA) therapieshepatitis C virus (HCV)pediatric organ transplant

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Johns Hopkins University of Medicine, Baltimore, MD 21287, USA.
  • Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD 21287, USA.
  • Division of Pediatric Infectious Diseases, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.

ORCID-Profile: Christopher Hartley, Paul K Sue, Wikrom Karnsakul

Zitieren

APA

Dilwali, N., Hartley, C., Sue, P. K., & Karnsakul, W. (2024). Use of Hepatitis C Viremic Donors to Expand the Pediatric Donor Pool. Pathogens. https://doi.org/10.3390/pathogens13110947

Vancouver

Dilwali N, Hartley C, Sue PK, Karnsakul W. Use of Hepatitis C Viremic Donors to Expand the Pediatric Donor Pool. Pathogens. 2024. doi:10.3390/pathogens13110947

BibTeX
@article{Dilwali2024,
  author = {Dilwali, Natasha and Hartley, Christopher and Sue, Paul K and Karnsakul, Wikrom},
  title = {Use of Hepatitis C Viremic Donors to Expand the Pediatric Donor Pool},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13110947}
}
Kostenlos starten →